Company: DAWN
Filing Date: 2025-02-25
Form Type: 10-K
Source: 0000950170-25-026654
Chunk: 5

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-02-25
Form: 10-K
Item: Item 15
Chunk 5
---
(1)	Financial Statements:

The financial statements required by Item 15(a) are filed as part of this Annual Report on Form 10-K under Item 8 “Financial Statements and Supplementary Data.”

(2)	Financial Statement Schedules

The financial statement schedules required by Item 15(a) are omitted because they are not applicable, not required or the required information is included in the financial statements or notes thereto as filed in Item 8 of this Annual Report on Form 10-K.

(3)	Exhibits.

    ExhibitNumber
       
    Description
        
    Form
         
    File No.
        
    ExhibitFilingDate
        
    Filed/ FurnishedHerewith

    3.1
     
    Restated Certificate of Incorporation, dated June 1, 2021, as amended June 22, 2023.
     
    10-Q
     
    001-40431
     
    August 7, 2023

    3.2
     
    Amended and Restated Bylaws, dated February 17, 2023.
     
    8-K
     
    001-40431
     
    February 23, 2023

    3.3
     
    Certificate of Ownership and Merger, dated December 23, 2021
     
    10-K
     
     001-40431
     
    March 7, 2022

    4.1
     
    Form of Common Stock Certificate
     
    S-1/A
     
    333-255754
     
    May 24, 2021

    4.2
     
    Amended and Restated Investors’ Rights Agreement, dated February 1, 2021, by and among Day One Biopharmaceuticals Holding Company, LLC and certain of its stockholders.
     
    S-1
     
    333-255754
     
    May 4, 2021

    4.3
     
    Form of Pre-Funded Warrant 
     
    8-K
     
    001-40431
     
    July 30, 2024

    4.4
     
    Form of Registration Rights Agreement
     
    8-K
     
    001-40431
     
    July 30, 2024

    4.5
     
    Description of Registrant’s Securities
     
    10-K
     
    001-